ARCHIVES

NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

December 28, 2012

Tobacco Council Announces 11 New Grant Awards

January 24, 1975

ASCO Urges Sustained Support For Cancer Research, Clinical Trials

March 27, 2009

CMS Inserts Unprecedented Conditions Into Medicare Coverage of Lung Screening

November 14, 2014

I-ELCAP: NEJM And Other Journals Seek Information On The Study’s Confidential Review From Henschke And Her Employers

May 6, 2011

Garb Denies He, Panel Said Contract Should Be Primary Funding Mechanism

March 17, 1978